Background: Idiopathic autonomic neuropathy is a severe, subacute disorder
with a presumed autoimmune basis. It is indistinguishable from the subacute
autonomic neuropathy that may accompany lung cancer or other tumors. Autoa
ntibodies specific for nicotinic acetylcholine receptors in the autonomic g
anglia are potentially pathogenic and may serve as serologic markers of var
ious forms of autoimmune autonomic neuropathy.
Methods: We tested serum from 157 patients with a variety of types of dysau
tonomia. Immunoprecipitation assays with iodine-125-labeled epibatidine and
solubilized human neuroblastoma acetylcholine receptors were used to detec
t autoantibodies that bound to or blocked ganglionic receptors.
Results: Ganglionic-receptor-binding antibodies were found in 19 of 46 pati
ents with idiopathic or paraneoplastic autonomic neuropathy (41 percent), i
n 6 of 67 patients with postural tachycardia syndrome, idiopathic gastroint
estinal dysmotility, or diabetic autonomic neuropathy (9 percent), and in n
one of 44 patients with other autonomic disorders. High levels of the bindi
ng antibodies correlated with more severe autonomic dysfunction (including
the presence of tonic pupils). Levels of these antibodies decreased in pati
ents who had clinical improvement. All seven patients with ganglionic-recep
tor-blocking antibodies had ganglionic-receptor-binding antibodies and had
idiopathic or paraneoplastic autonomic neuropathy.
Conclusions: Seropositivity for antibodies that bind to or block ganglionic
acetylcholine receptors identifies patients with various forms of autoimmu
ne autonomic neuropathy and distinguishes these disorders from other types
of dysautonomia. The positive correlation between high levels of ganglionic
-receptor antibodies and the severity of autonomic dysfunction suggests tha
t the antibodies have a pathogenic role in these types of neuropathy. (N En
gl J Med 2000;343:847-55.) (C) 2000, Massachusetts Medical Society.